Business Wire

SwitchDin’s Technology Selected for World-First Project to Increase Solar Hosting Capacity for Electricity Distribution Networks

1.10.2020 23:00:00 EEST | Business Wire | Press release

Share

SwitchDin, an Australian energy management software company, has been retained by distribution networks, SA Power Networks and AusNet Services, to provide a global-first solution that will allow networks to create flexible solar export limits to accommodate the growth of rooftop solar photovoltaic (PV) systems that are connected to the grid.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005065/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

SwitchDin CEO Dr Andrew Mears with SwitchDin Droplet controller (Photo: Business Wire)

The installation of PV systems is growing at a rate of more than 200,000 each year in Australia’s National Electricity Market (NEM), and distribution networks are reaching the limit of their ability to host rooftop solar in some areas. This flexible export capability will allow SA Power Networks and AusNet Services to offer an alternative to the strict export limits currently required to address these challenges, increasing the penetration of renewable energy, creating more value for customers and improving the security of the grid.

The project is backed with over A$2 million in direct funding by the Australian Renewable Energy Agency (ARENA), with additional financial contributions from SwitchDin, SA Power Networks, AusNet Services and inverter manufacturers involved in the program. A 12 month trial involving a group of 600 customers in South Australia and Victoria will test the viability of this approach so it can be offered as a standard service to solar customers in future.

SwitchDin will lead in the project’s integration architecture design and will provide the core software platform for SA Power Networks and AusNet Services to support the flexible export functionality, based on the international ‘Smart Grid’ standard IEEE 2030.5. The flexible export capability will be enabled for solar inverters through connection to SwitchDin’s Droplet controller devices, or by connection via the internet into SwitchDin’s IEEE 2030.5 utility server platform.

Dr Andrew Mears, CEO of SwitchDin said, “SwitchDin is proud to be developing the technology backbone of the Flexible Exports project in South Australia and Victoria. This is another example of how we are working with Australia’s most progressive network service companies and the world’s best inverter manufacturers to bring smart software solutions to maximise the value of distributed energy resources such as rooftop solar for consumers and energy service providers alike.

“SwitchDin’s goal is to deliver smarter and cheaper clean energy services on the grid for the benefit of everyone. In the Australian market, the pressing issue is high penetration of rooftop solar, but our platform can also support battery storage and key loads such as heat pumps and electric vehicles as part of a complete ‘energy flexibility’ toolkit.”

“We want more solar, not less,” said Paul Roberts, Manager Corporate Affairs at SA Power Networks. “SA Power Networks is passionate about supporting South Australia’s energy transition and we have a number of initiatives underway that have the potential to double the amount of renewable energy the SA electricity distribution network can accommodate over the next five years.”

“By working with SwitchDin and the other project partners, SA Power Networks and AusNet Services are paving the way for distribution networks to continue to host the rooftop solar systems being installed by customers whilst reducing the need for major investment in network upgrades. This is a winning value proposition for energy distribution network companies globally who are grappling with how to meet customers’ expectations to be more energy independent.”

Building on past successes

SwitchDin solves one of the great roadblocks faced by today’s electricity system, the management at-scale of many distributed energy resources such as small-scale solar, batteries and loads like electric vehicles and HVAC systems. The company’s technology bridges the gap between traditional energy utilities, manufacturers and energy end-users by bringing rich data, intelligence and real-time fleet control capabilities to these assets.

In addition to the Flexible Exports project, SwitchDin is actively working with utilities and equipment manufacturers from around the world to build the grid of the future. The company connects and manages distributed assets with its Droplet controllers and smart software and provides cloud-level orchestration using its StormCloud management platform. SwitchDin can connect with upstream third party and utility distribution management systems or energy trading tools to ensure a smooth transition to clean and affordable electricity.

Note to Editor: Hi-res images can be downloaded here.

About SwitchDin:

SwitchDin is an energy technology company that plays a critical role in the energy transition by making distributed energy resources (DERs) such as solar PV and battery storage smart, visible and controllable. SwitchDin is paving the way for the integration of more renewables into the world’s energy system. Working in collaboration with energy utilities, equipment manufacturers, technology providers and facility managers, SwitchDin’s virtual power plant and microgrid management platform delivers new partnerships that unlock value for everyone connected to the grid. www.switchdin.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

James Martin
+61 478 587 396
james.martin@switchdin.com

Gabriel Wong / Olivia Smith for SwitchDin
+61 432 177 005 / +61 402 044 811
gabriel@positivegood.com.au / olivia@positivegood.com.au

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye